Riskpilot← Back to searchSign inGet full accessAoptik Halmstad AB
ABActiveOrg 5593667875Skaraborgsvägen 40Retail sale of medical and orthopaedic goods · NACE 4774Est. 20221-4 employees
Revenue 2025
SEK 3,1M
+44% vs 2024
EBITDA margin
0.1%
+108% vs 2024
Equity ratio
1.2%
Financial strength
Net profit 2025
SEK 676
+100% vs 2024
| Revenue | SEK 3,1M | +44% |
| EBITDA | SEK 4K | +108% |
| Net profit | SEK 676 | +100% |
| Total assets | SEK 2,3M | +1% |
| Equity | SEK 26K | +1% |
| Employees | — | — |
Legal name
Aoptik Halmstad AB
Org number
5593667875
Legal form
Aktiebolag
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
22 februari 2022
Share capital
SEK 25 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att äga fastigheter och bedriva fastighetsförvaltning samt förvalta aktier och därmed förenlig verksamhet.
Address
Skaraborgsvägen 40
Email
johan.olofsson@aoptik.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 2 137 | 3 074 |
| Staff expenses | — | −0 | — | — | −733 |
| EBITDA | −5 | −5 | −320 | −51 | 4 |
| Depreciation & amort. | −0 | −0 | −23 | −122 | −122 |
| EBIT | −5 | −5 | −343 | −173 | −118 |
| Net financials | — | 0 | — | 3 | −81 |
| Profit before tax | −5 | −5 | −343 | −170 | 1 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −5 | −5 | −343 | −170 | 1 |
| Item | 2022 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 25 | 25 | 2 528 | 2 247 | 2 260 |
| Equity | 20 | 20 | 25 | 26 | 26 |
| Long-term debt | 0 | 0 | 807 | 0 | 0 |
| Short-term debt | 5 | 5 | 1 696 | 2 222 | 2 233 |
| Total debt | 5 | 5 | 2 503 | 2 222 | 2 233 |
EBITDA margin
0.1%
This company
15.8%
Market median
-99% vs market
20222025
Equity ratio
1.2%
This company
38.2%
Market median
-97% vs market
20222025
Return on equity
2.6%
This company
18.4%
Market median
-86% vs market
20222025
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20222025
Asset turnover
1.36×
This company
1.12×
Market median
+21% vs market
20222025
Debt / equity
85.11×
This company
0.62×
Market median
-13627% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-02-22 – 2022-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-02-01 – 2022-08-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PR Auditor Substitute | Auditor Substitute | 2022 | — | — |
| Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Ettöringen AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Aoptik Halmstad AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Rikard Johelid | Auditor Substitute | 0 companies |
| Carl-Peter Bertil Kalle Wrane | Audit | 0 companies |
| Johan Gunnar Bylund | Deputy Board Member | 0 companies |
| Per Johan Olofsson | Board of Directors | 0 companies |